Who
Linda Baddour
Director
Company insider
Files Form 4 as: Director, CryoPort; Director, Waters; Executive VP & CFO, PRA Health Sciences; EVP and CFO, PRA International; Chief Financial Officer, Pharmaceutical Product Development.
In numbers
- Trades disclosed
- 242
- Buys
- 0
- Sells
- 20
- Bought
- $0
- Sold
- $48.6M
- Companies
- 5
- Companies where not an officer
- 2
- First trade
- 22 Feb 2006
- Last trade
- 5 Jun 2026
- Last filed
- 9 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Jun 2026filed 9 Jun 2026 | CYRX CryoPortLife-science tools | SEC FORM 4 Code A | —10,350 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | CYRX CryoPortoption or derivative · Life-science tools | SEC FORM 4 Code A | —16,077 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | CYRX CryoPortoption or derivative · Life-science tools | SEC FORM 4 Code A | —16,077 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | CYRX CryoPortLife-science tools | SEC FORM 4 Code A | —10,350 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | WAT WatersLife-science tools | SEC FORM 4 Code A | —23 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | WAT Watersoption or derivative · Life-science tools | SEC FORM 4 Code A | —57 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | WAT Watersoption or derivative · Life-science tools | SEC FORM 4 Code A | —57 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | WAT WatersLife-science tools | SEC FORM 4 Code A | —23 at $0.00 | filing |
| 2 Jan 2026filed 5 Jan 2026 | WAT WatersLife-science tools | SEC FORM 4 Code A | —307 at $0.00 | filing |
| 2 Jan 2026filed 5 Jan 2026 | WAT Watersoption or derivative · Life-science tools | SEC FORM 4 Code A | —828 at $0.00 | filing |
| 2 Jan 2026filed 5 Jan 2026 | WAT Watersoption or derivative · Life-science tools | SEC FORM 4 Code A | —828 at $0.00 | filing |
| 2 Jan 2026filed 5 Jan 2026 | WAT WatersLife-science tools | SEC FORM 4 Code A | —307 at $0.00 | filing |
| 6 Jun 2025filed 10 Jun 2025 | CYRX CryoPortoption or derivative · Life-science tools | SEC FORM 4 Code A | —41,098 at $0.00 | filing |
| 6 Jun 2025filed 10 Jun 2025 | CYRX CryoPortLife-science tools | SEC FORM 4 Code A | —23,214 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | WAT Watersoption or derivative · Life-science tools | SEC FORM 4 Code A | —818 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | WAT WatersLife-science tools | SEC FORM 4 Code A | —319 at $0.00 | filing |
| 17 May 2024filed 21 May 2024 | CYRX CryoPortoption or derivative · Life-science tools | SEC FORM 4 Code A | —23,830 at $0.00 | filing |
| 17 May 2024filed 21 May 2024 | CYRX CryoPortLife-science tools | SEC FORM 4 Code A | —12,845 at $0.00 | filing |
| 15 Mar 2024filed 19 Mar 2024 | CYRX CryoPortoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,111 at $0.00 | filing |
| 15 Mar 2024filed 19 Mar 2024 | CYRX CryoPortLife-science tools | SEC FORM 4 Code M | —1,111 at $0.00 | filing |
News
Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026WAT · prnewswire.com · 23 Oct 2026Waters (NYSE:WAT) Reaches New 12-Month High – Here's WhyWAT · tickerreport.com · 21 Oct 2026Waters: Integrating Anthropic AI Into Laboratory WorkflowsWAT · healthcare-digital.com · 20 Oct 2026
0 headlines in the last 90 days name Linda Baddour; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.